Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MGAM | O43451 | 1/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | SI | P14410 | 1/20 | 0.31 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.30 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15823492 | 0.77 | ALDH1A1 (0.31) | — | |
| SCHEMBL2106286 | 0.77 | NPSR1 (0.35) | MEN1KMT2AALOX15TSHRNPSR1 | |
| SCHEMBL28507503 | 0.76 | ALOX15 (0.37) | ALOX15 | |
| Ammonia Solution, Strong SCHEMBL28210842 | 0.75 | NPSR1 (0.33) | ALOX15TSHRNPSR1 | |
| SCHEMBL27485483 | 0.74 | ALDH1A1 (0.37) | TSHR | |
| SCHEMBL3844398 | 0.74 | — | — | |
| SCHEMBL6053661 | 0.65 | — | — | |
| SCHEMBL4350855 | 0.65 | ALDH1A1 (0.30) | — | |
| SCHEMBL6964767 | 0.65 | MGAM (0.35) | MGAMGAASIMGAM2MEN1 | |
| SCHEMBL19182993 | 0.65 | ALDH1A1 (0.32) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9249262-B2 | Curable organic polymer and method for production thereof, and curable composition containing the same | KANEKA CORPORATION (JP) | 2016-02-02 | — | — | US | disclosed |
| US-20090264612-A1 | ALKOXYSILANE-TERMINATED PREPOLYMERS | WACKER CHEMIE AG (DE) | 2009-10-22 | — | — | US | disclosed |
| US-20090247712-A1 | CURABLE ORGANIC POLYMER AND METHOD FOR PRODUCTION THEREOF, AND CURABLE COMPOSITION CONTAINING THE SAME | KANEKA CORPORATION (JP) | 2009-10-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090264612-A1 | ALKOXYSILANE-TERMINATED PREPOLYMERS | MYB, ACMSD, PLOD1 | MGAM 660/4885GAA 1195/4885SI 332/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.